The McIsaac Score: A Clinical Prediction Tool for Streptococcal Pharyngitis
The McIsaac score is a 5-point clinical prediction rule (0-5 points) that estimates the probability of Group A Streptococcal (GAS) pharyngitis, but it should NOT be used alone to diagnose or exclude streptococcal pharyngitis—laboratory confirmation with rapid antigen detection test (RADT) or throat culture remains essential 1.
Score Components
The McIsaac score assigns points based on:
- Temperature >38°C (100.4°F): +1 point
- Absence of cough: +1 point
- Swollen, tender anterior cervical lymph nodes: +1 point
- Tonsillar swelling or exudate: +1 point
- Age modifier:
- Age 3-14 years: +1 point
- Age 15-44 years: 0 points
- Age ≥45 years: -1 point
Probability of GAS Infection by Score
Large-scale validation studies demonstrate the following GAS-positive rates 2:
- Score 0: 8% probability
- Score 1: 14% probability
- Score 2: 23% probability
- Score 3: 37% probability
- Score 4: 55% probability
Critical Limitations and Clinical Application
The score cannot reliably differentiate bacterial from viral pharyngitis with sufficient precision for clinical decision-making 1, 3. Even patients with all clinical features (maximum score) have GAS confirmed only 35-50% of the time 1. Recent meta-analysis confirms that both Centor and McIsaac scores are "equally ineffective at triaging patients who need antibiotics" 3.
When to Skip Testing Entirely
Do NOT test or treat when obvious viral features are present 1:
- Cough
- Rhinorrhea (runny nose)
- Hoarseness
- Oral ulcers
- Conjunctivitis
These features strongly indicate viral etiology and testing is unnecessary 1, 4.
Recommended Testing Strategy
For children and adolescents (ages 3-18):
- Use clinical scoring to identify low-risk patients (score 0-1) where testing may be deferred
- For scores ≥2, perform RADT
- If RADT is negative, back it up with throat culture (sensitivity of RADT <90%) 1
- If RADT is positive, treat immediately—no backup culture needed (high specificity) 1
For adults:
- Perform RADT for suspected cases
- Backup throat culture generally NOT needed due to low GAS prevalence (5-15%) and extremely low risk of acute rheumatic fever in adults 1
- Exception: Consider backup culture if maximizing diagnostic sensitivity is critical 1
Do NOT test children <3 years old unless specific risk factors exist (e.g., older sibling with confirmed GAS), as both the disease and acute rheumatic fever are rare in this age group 1.
Why Laboratory Confirmation Matters
The primary goal of treating GAS pharyngitis is preventing acute rheumatic fever (treatment effective within 9 days of symptom onset), not just symptom relief 1. Clinical diagnosis alone leads to massive antibiotic overuse—up to 70% of patients with sore throats receive antibiotics when only 20-30% actually have GAS 1. This drives antibiotic resistance without improving outcomes 1.
The McIsaac score helps identify who needs testing, not who needs antibiotics 5. Treatment decisions must be based on positive laboratory confirmation, not clinical scores alone 1, 3.